Literature DB >> 2845422

Regulation by cAMP and vasoactive intestinal peptide of phosphorylation of specific proteins in striatal cells in culture.

J A Girault1, I A Shalaby, N L Rosen, P Greengard.   

Abstract

We have studied three low molecular weight phosphoproteins, ARPP-16, ARPP-19, and ARPP-21 (cAMP-regulated phosphoproteins of Mr 16,000, 19,000, and 21,000, respectively) in reaggregate cultures from various regions of fetal mouse brain. ARPP-16 and ARPP-21 were detected only in striatal and cortical cultures. In contrast, ARP-19, which is structurally related to ARPP-16, was also present in reaggregate cultures prepared from thalamus and ventral and dorsal mesencephalon, as well as in monolayer cultures of astroglial cells. In striatal aggregates cultured over a 3-week period, the relative levels of ARPP-16, ARPP-21, and synapsin I/protein IIIa (synaptic vesicle-associated phosphoproteins closely related to each other and treated as a single entity in the present study) increased with time, whereas the level of ARPP-19 decreased. Incubation of striatal aggregates with 8-Br-cAMP, forskolin, or vasoactive intestinal peptide increased the phosphorylation of all these proteins. We conclude that the state of phosphorylation of two proteins enriched in specific neurons (ARPP-16 and ARPP-21) and two more widely distributed proteins (ARPP-19 and synapsin I/protein IIIa) is regulated by cAMP and vasoactive intestinal peptide in striatal cells in culture. These phosphoproteins may therefore play a role in mediating some of the actions of vasoactive intestinal peptide in the caudate-putamen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845422      PMCID: PMC282279          DOI: 10.1073/pnas.85.20.7790

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Depolarizing agents and cyclic nucleotides regulate the phosphorylation of specific neuronal proteins in rat cerebral cortex slices.

Authors:  J Forn; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.

Authors:  C C Ouimet; P E Miller; H C Hemmings; S I Walaas; P Greengard
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

5.  Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. I. Particulate systems.

Authors:  S I Walaas; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

6.  Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems.

Authors:  S I Walaas; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

7.  Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain.

Authors:  M Quik; L L Iversen; S R Bloom
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro.

Authors:  L M Hemmendinger; B B Garber; P C Hoffmann; A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

Review 9.  Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology.

Authors:  P J Magistretti; J H Morrison
Journal:  Neuroscience       Date:  1988-02       Impact factor: 3.590

10.  Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell culture.

Authors:  L K Kaczmarek; K R Jennings; F Strumwasser; A C Nairn; U Walter; F D Wilson; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  12 in total

Review 1.  Protein phosphatases and their regulation in the control of mitosis.

Authors:  Satoru Mochida; Tim Hunt
Journal:  EMBO Rep       Date:  2012-03       Impact factor: 8.807

2.  Multidimensional Top-Down Proteomics of Brain-Region-Specific Mouse Brain Proteoforms Responsive to Cocaine and Estradiol.

Authors:  Hae-Min Park; Rosalba Satta; Roderick G Davis; Young Ah Goo; Richard D LeDuc; Ryan T Fellers; Joseph B Greer; Elena V Romanova; Stanislav S Rubakhin; Rex Tai; Paul M Thomas; Jonathan V Sweedler; Neil L Kelleher; Steven M Patrie; Amy W Lasek
Journal:  J Proteome Res       Date:  2019-10-02       Impact factor: 4.466

3.  Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model.

Authors:  Xinli Tian; Adam Richard; Madison Wynne El-Saadi; Aakriti Bhandari; Brian Latimer; Isabella Van Savage; Kevlyn Holmes; Ronald L Klein; Donard Dwyer; Nicholas E Goeders; X William Yang; Xiao-Hong Lu
Journal:  Mol Psychiatry       Date:  2019-08-23       Impact factor: 15.992

Review 4.  VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

Authors:  J M Muller; V Lelievre; L Becq-Giraudon; A C Meunier
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

5.  cAMP-dependent, long-lasting inhibition of a K+ current in mammalian neurons.

Authors:  H Ansanay; A Dumuis; M Sebben; J Bockaert; L Fagni
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

6.  Neuronal localization of the tyrosine-specific protein kinase p62c-yes in rat basal ganglia.

Authors:  S I Walaas; Y H Zhao; M Sudol
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

7.  Backbone 1H, 15N, and 13C resonance assignments of ARPP-19.

Authors:  H B Huang; Y C Chen; A Horiuchi; L H Tsai; H T Liu; C L Chyan; M J Hsieh; C K Liu; F M Lin; P Greengard; A C Nairn; M S Shiao; T H Lin
Journal:  J Biomol NMR       Date:  2001-04       Impact factor: 2.835

8.  ARPP-39, a membrane-associated substrate for cyclic AMP-dependent protein kinase present in neostriatal neurons.

Authors:  S I Walaas; P Greengard
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

9.  Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.

Authors:  J A Girault; R Raisman-Vozari; Y Agid; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Localization of DARPP-32 immunoreactive neurons in the bed nucleus of the stria terminalis and central nucleus of the amygdala: co-distribution with axons containing tyrosine hydroxylase, vasoactive intestinal polypeptide, and calcitonin gene-related peptide.

Authors:  E L Gustafson; P Greengard
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.